New combo therapy targets tough blood cancers
NCT ID NCT02005289
Summary
This study tested whether combining two drugs could help control chronic lymphocytic leukemia and related blood cancers. It included 41 adults whose cancer had returned after previous treatment or who hadn't yet received treatment. Researchers gave patients an antibody drug that targets cancer cells plus another drug that helps the immune system fight cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
Conditions
Explore the condition pages connected to this study.